Technology
Health
Pharmaceutical

G1 Therapeutics

$38.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.63 (4.41%) As of 2:58 PM EDT today
+$1.63 (4.41%) Today

Why Robinhood?

You can buy or sell GTHX and other stocks, options, ETFs, and crypto commission-free!

About GTHX

G1 Therapeutics, Inc. Common Stock, also called G1 Therapeutics, is a clinical-stage biopharmaceutical company that focuses on the discovery and development of novel therapies to address significant unmet needs in oncology. Read More The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

Employees
84
Headquarters
Research Triangle Park, North Carolina
Founded
2008
Market Cap
1.38B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
540.31K
High Today
$38.72
Low Today
$36.30
Open Price
$37.89
Volume
141.23K
52 Week High
$69.57
52 Week Low
$13.87

Collections

Technology
Health
Pharmaceutical
Therapy
Cancer Prevention
Medical
Biopharmaceutical
2017 IPO

GTHX News

ReutersAug 10

Edited Transcript of GTHX.O earnings conference call or presentation 7-Aug-19 8:30pm GMT

10

GTHX Earnings

-$0.82
-$0.74
-$0.66
-$0.58
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.72 per share
Actual
-$0.82 per share

More GTHX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.